Blockade of store-operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory response

Store-operated calcium entry (SOCE) is an important pathway for calcium signaling that regulates calcium influx across the plasma membrane upon the depletion of calcium stores in the endoplasmic reticulum. SOCE participates in regulating a number of physiological processes including cell proliferati...

Full description

Bibliographic Details
Main Authors: Abdullah S. Alhamed, Mohammed Alqinyah, Musab A. Alsufayan, Ibrahim A. Alhaydan, Yasseen A. Alassmrry, Hajar O. Alnefaie, Mohammad M. Algahtani, Adel F. Alghaith, Hussain N. Alhamami, Abdullah M. Albogami, Khalid Alhazzani, Alanazi AZ
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Saudi Pharmaceutical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016422003085
_version_ 1811159993359007744
author Abdullah S. Alhamed
Mohammed Alqinyah
Musab A. Alsufayan
Ibrahim A. Alhaydan
Yasseen A. Alassmrry
Hajar O. Alnefaie
Mohammad M. Algahtani
Adel F. Alghaith
Hussain N. Alhamami
Abdullah M. Albogami
Khalid Alhazzani
Alanazi AZ
author_facet Abdullah S. Alhamed
Mohammed Alqinyah
Musab A. Alsufayan
Ibrahim A. Alhaydan
Yasseen A. Alassmrry
Hajar O. Alnefaie
Mohammad M. Algahtani
Adel F. Alghaith
Hussain N. Alhamami
Abdullah M. Albogami
Khalid Alhazzani
Alanazi AZ
author_sort Abdullah S. Alhamed
collection DOAJ
description Store-operated calcium entry (SOCE) is an important pathway for calcium signaling that regulates calcium influx across the plasma membrane upon the depletion of calcium stores in the endoplasmic reticulum. SOCE participates in regulating a number of physiological processes including cell proliferation and migration while SOCE dysregulation has been linked with pathophysiological conditions such as inflammation and cancer. The crosslink between cancer and inflammation has been well-established where abundant evidence demonstrate that inflammation plays a role in cancer pathophysiology and the response of cancer cells to chemotherapeutic agents including cisplatin. Indeed, the efficacy of cisplatin against cancer cells is reduced by inflammation. Interestingly, it was shown that SOCE enhances inflammatory signaling in immune cells. Therefore, the main objectives of this study are to examine the impact of SOCE inhibition on the cisplatin sensitivity of breast cancer cells and to explore its related mechanism in modulating the inflammatory response in breast cancer cells. Our findings showed that SOCE inhibitor (BTP2) enhanced cisplatin cytotoxicity against resistant breast cancer cells via inhibition of cell proliferation and migration as well as induction of apoptosis. We also found an upregulation in the gene expression of two major components of SOCE, STIM1 and ORAI1, in cisplatin-resistant breast cancer cells compared to cisplatin-sensitive breast cancer cells. In addition, cisplatin treatment increased the gene expression of STIM1 and ORAI1 in cisplatin-resistant breast cancer cells. Finally, this study also demonstrated that cisplatin therapy caused an increase in the gene expression of inflammatory mediators COX2, IL-8, and TNF-α as well as COX2 protein and upon SOCE inhibition using BTP2, the effect of cisplatin on the inflammatory mediators was reversed. Altogether, this study has proven the pivotal role of SOCE in cisplatin resistance of breast cancer cells and showed the importance of targeting this pathway in improving breast cancer therapy.
first_indexed 2024-04-10T05:50:10Z
format Article
id doaj.art-e0164ae4c5194d928d0127fd9b5eff20
institution Directory Open Access Journal
issn 1319-0164
language English
last_indexed 2024-04-10T05:50:10Z
publishDate 2023-02-01
publisher Elsevier
record_format Article
series Saudi Pharmaceutical Journal
spelling doaj.art-e0164ae4c5194d928d0127fd9b5eff202023-03-05T04:23:22ZengElsevierSaudi Pharmaceutical Journal1319-01642023-02-01312245254Blockade of store-operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory responseAbdullah S. Alhamed0Mohammed Alqinyah1Musab A. Alsufayan2Ibrahim A. Alhaydan3Yasseen A. Alassmrry4Hajar O. Alnefaie5Mohammad M. Algahtani6Adel F. Alghaith7Hussain N. Alhamami8Abdullah M. Albogami9Khalid Alhazzani10Alanazi AZ11Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia; Corresponding author.Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of pharmaceutics, College of pharmacy, king Saud university, P.O. Box 2457, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi ArabiaStore-operated calcium entry (SOCE) is an important pathway for calcium signaling that regulates calcium influx across the plasma membrane upon the depletion of calcium stores in the endoplasmic reticulum. SOCE participates in regulating a number of physiological processes including cell proliferation and migration while SOCE dysregulation has been linked with pathophysiological conditions such as inflammation and cancer. The crosslink between cancer and inflammation has been well-established where abundant evidence demonstrate that inflammation plays a role in cancer pathophysiology and the response of cancer cells to chemotherapeutic agents including cisplatin. Indeed, the efficacy of cisplatin against cancer cells is reduced by inflammation. Interestingly, it was shown that SOCE enhances inflammatory signaling in immune cells. Therefore, the main objectives of this study are to examine the impact of SOCE inhibition on the cisplatin sensitivity of breast cancer cells and to explore its related mechanism in modulating the inflammatory response in breast cancer cells. Our findings showed that SOCE inhibitor (BTP2) enhanced cisplatin cytotoxicity against resistant breast cancer cells via inhibition of cell proliferation and migration as well as induction of apoptosis. We also found an upregulation in the gene expression of two major components of SOCE, STIM1 and ORAI1, in cisplatin-resistant breast cancer cells compared to cisplatin-sensitive breast cancer cells. In addition, cisplatin treatment increased the gene expression of STIM1 and ORAI1 in cisplatin-resistant breast cancer cells. Finally, this study also demonstrated that cisplatin therapy caused an increase in the gene expression of inflammatory mediators COX2, IL-8, and TNF-α as well as COX2 protein and upon SOCE inhibition using BTP2, the effect of cisplatin on the inflammatory mediators was reversed. Altogether, this study has proven the pivotal role of SOCE in cisplatin resistance of breast cancer cells and showed the importance of targeting this pathway in improving breast cancer therapy.http://www.sciencedirect.com/science/article/pii/S1319016422003085Breast CancerCisplatinSOCEAnd inflammation
spellingShingle Abdullah S. Alhamed
Mohammed Alqinyah
Musab A. Alsufayan
Ibrahim A. Alhaydan
Yasseen A. Alassmrry
Hajar O. Alnefaie
Mohammad M. Algahtani
Adel F. Alghaith
Hussain N. Alhamami
Abdullah M. Albogami
Khalid Alhazzani
Alanazi AZ
Blockade of store-operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory response
Saudi Pharmaceutical Journal
Breast Cancer
Cisplatin
SOCE
And inflammation
title Blockade of store-operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory response
title_full Blockade of store-operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory response
title_fullStr Blockade of store-operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory response
title_full_unstemmed Blockade of store-operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory response
title_short Blockade of store-operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory response
title_sort blockade of store operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory response
topic Breast Cancer
Cisplatin
SOCE
And inflammation
url http://www.sciencedirect.com/science/article/pii/S1319016422003085
work_keys_str_mv AT abdullahsalhamed blockadeofstoreoperatedcalciumentrysensitizesbreastcancercellstocisplatintherapyviamodulatinginflammatoryresponse
AT mohammedalqinyah blockadeofstoreoperatedcalciumentrysensitizesbreastcancercellstocisplatintherapyviamodulatinginflammatoryresponse
AT musabaalsufayan blockadeofstoreoperatedcalciumentrysensitizesbreastcancercellstocisplatintherapyviamodulatinginflammatoryresponse
AT ibrahimaalhaydan blockadeofstoreoperatedcalciumentrysensitizesbreastcancercellstocisplatintherapyviamodulatinginflammatoryresponse
AT yasseenaalassmrry blockadeofstoreoperatedcalciumentrysensitizesbreastcancercellstocisplatintherapyviamodulatinginflammatoryresponse
AT hajaroalnefaie blockadeofstoreoperatedcalciumentrysensitizesbreastcancercellstocisplatintherapyviamodulatinginflammatoryresponse
AT mohammadmalgahtani blockadeofstoreoperatedcalciumentrysensitizesbreastcancercellstocisplatintherapyviamodulatinginflammatoryresponse
AT adelfalghaith blockadeofstoreoperatedcalciumentrysensitizesbreastcancercellstocisplatintherapyviamodulatinginflammatoryresponse
AT hussainnalhamami blockadeofstoreoperatedcalciumentrysensitizesbreastcancercellstocisplatintherapyviamodulatinginflammatoryresponse
AT abdullahmalbogami blockadeofstoreoperatedcalciumentrysensitizesbreastcancercellstocisplatintherapyviamodulatinginflammatoryresponse
AT khalidalhazzani blockadeofstoreoperatedcalciumentrysensitizesbreastcancercellstocisplatintherapyviamodulatinginflammatoryresponse
AT alanaziaz blockadeofstoreoperatedcalciumentrysensitizesbreastcancercellstocisplatintherapyviamodulatinginflammatoryresponse